MetLife Investment Management’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153K | Buy |
41,800
+6,677
| +19% | +$24.4K | ﹤0.01% | 2327 |
|
|
2025
Q1 | $152K | Sell |
35,123
-1,470
| -4% | -$6.35K | ﹤0.01% | 2333 |
|
|
2024
Q4 | $117K | Buy |
36,593
+9,465
| +35% | +$30.3K | ﹤0.01% | 2553 |
|
|
2024
Q3 | $77.6K | Sell |
27,128
-14,727
| -35% | -$42.1K | ﹤0.01% | 2701 |
|
|
2024
Q2 | $117K | Buy |
41,855
+5,020
| +14% | +$14.1K | ﹤0.01% | 2529 |
|
|
2024
Q1 | $105K | Sell |
36,835
-1,190
| -3% | -$3.38K | ﹤0.01% | 2511 |
|
|
2023
Q4 | $156K | Hold |
38,025
| – | – | ﹤0.01% | 2375 |
|
|
2023
Q3 | $121K | Hold |
38,025
| – | – | ﹤0.01% | 2482 |
|
|
2023
Q2 | $126K | Hold |
38,025
| – | – | ﹤0.01% | 2544 |
|
|
2023
Q1 | $81K | Buy |
38,025
+15,356
| +68% | +$32.7K | ﹤0.01% | 2632 |
|
|
2022
Q4 | $61K | Sell |
22,669
-15,279
| -40% | -$41.1K | ﹤0.01% | 2733 |
|
|
2022
Q3 | $123K | Buy |
37,948
+16,513
| +77% | +$53.5K | ﹤0.01% | 2576 |
|
|
2022
Q2 | $105K | Sell |
21,435
-18,204
| -46% | -$88.8K | ﹤0.01% | 2695 |
|
|
2022
Q1 | $302K | Buy |
39,639
+24,906
| +169% | +$190K | ﹤0.01% | 2093 |
|
|
2021
Q4 | $136K | Hold |
14,733
| – | – | ﹤0.01% | 2286 |
|
|
2021
Q3 | $210K | Hold |
14,733
| – | – | ﹤0.01% | 2071 |
|
|
2021
Q2 | $245K | Buy |
14,733
+4,126
| +39% | +$68.6K | ﹤0.01% | 2026 |
|
|
2021
Q1 | $193K | Buy |
+10,607
| New | +$193K | ﹤0.01% | 2069 |
|